281 related articles for article (PubMed ID: 10958708)
1. An evidence-based review of ACE inhibitors in incipient diabetic nephropathy.
Haider A; Oh P; Peloso PM
Can J Clin Pharmacol; 2000; 7(2):115-9. PubMed ID: 10958708
[TBL] [Abstract][Full Text] [Related]
2. Losartan in diabetic nephropathy.
Perico N; Ruggenenti P; Remuzzi G
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
[TBL] [Abstract][Full Text] [Related]
3. [Guidelines for diagnosis and therapy of diabetic nephropathy].
De Ferrari G;
G Ital Nefrol; 2003; 20 Suppl 24():S96-108. PubMed ID: 14666506
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
6. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
Cantarovich F; Rangoonwala B
Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
[TBL] [Abstract][Full Text] [Related]
8. Resolution of early stage diabetic nephropathy in an obese diabetic patient after gastric bypass.
Pérez G; Devaud N; Escalona A; Downey P
Obes Surg; 2006 Oct; 16(10):1388-91. PubMed ID: 17059753
[TBL] [Abstract][Full Text] [Related]
9. Treatment of diabetic nephropathy in its early stages.
Deferrari G; Ravera M; Berruti V
Diabetes Metab Res Rev; 2003; 19(2):101-14. PubMed ID: 12673778
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of diabetic nephropathy. Effects of ACE inhibition on microcirculation].
Haak T; Haak E; Jungmann E; Kusterer K; Usadel KH
Fortschr Med; 1997 Dec; 115(35-36):26-9. PubMed ID: 9499637
[TBL] [Abstract][Full Text] [Related]
11. Management of nephropathy in patients with type 2 diabetes.
Critchley JA; Zhao HL; Tomlinson B; Leung W; Thomas GN; Chan JC; Cockram CS
Chin Med J (Engl); 2002 Jan; 115(1):129-35. PubMed ID: 11930647
[TBL] [Abstract][Full Text] [Related]
12. [Effect of blood glucose and blood pressure control on progression of diabetic nephropathy].
Schwarz C; Oberbauer R
Wien Klin Wochenschr; 2000 Nov; 112(21):907-11. PubMed ID: 11144004
[TBL] [Abstract][Full Text] [Related]
13. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
Ravera M; Deferrari L; Ratto E; Vettoretti S; Parodi D; Deferrari G
Ital Heart J Suppl; 2003 Mar; 4(3):210-6. PubMed ID: 12784755
[TBL] [Abstract][Full Text] [Related]
14. [Prevention and remission of diabetic nephropathy].
Sugimoto T; Nakamura Y; Makino H
Nihon Rinsho; 2003 Jul; 61(7):1167-71. PubMed ID: 12877079
[TBL] [Abstract][Full Text] [Related]
15. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapeutic strategies in diabetic nephropathy.
Ravera M; Re M; Weiss U; Deferrari L; Deferrari G
J Nephrol; 2007; 20 Suppl 12():S23-32. PubMed ID: 18050139
[TBL] [Abstract][Full Text] [Related]
17. [Early detection and control of risk factors in diabetic nephropathy].
Fernández López MT; Isidro San Juan ML; Cordido F
An Med Interna; 1998 Nov; 15(11):600-5. PubMed ID: 9882860
[TBL] [Abstract][Full Text] [Related]
18. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.
Poulsen PL
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749
[TBL] [Abstract][Full Text] [Related]
19. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
20. Use of angiotensin-converting enzyme inhibitors in patients with diabetic nephropathy.
How HY; Sibai BM
J Matern Fetal Neonatal Med; 2002 Dec; 12(6):402-7. PubMed ID: 12683651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
